The treadmill segment by product is estimated to lead the market growth during the forecast period.
According to this study, the Asia Pacific cardiac rehabilitation market is expected to reach US$ 566.21 million by 2028 from US$ 336.45 million in 2020; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The report highlights trends prevailing in the Asia Pacific cardiac rehabilitation market and the factors driving market along with those that act as hindrances.
The Asia Pacific cardiac rehabilitation market, by type, is segmented into heart rate monitor, stabilization balls, treadmill, rower, elliptical trainer, blood pressure monitor, stationary bicycle, and others. The treadmill segment held the largest share of the market in 2020, whereas the blood pressure monitor segment is anticipated to register the highest CAGR in the market during the forecast period.
CR is an evidence-based, multidisciplinary intervention conferred to enhance health consequences and quality of life when used as secondary prevention. Several government initiatives are considered to have a high impact on the market. Increasing awareness regarding the CR, growing referral of eligible patients, and reducing system and limitations of the patient cooperation in promoting the enrolment, referral, and participation rates in CR programs. Several manufacturers are working on advanced cardiac rehabilitation products. Effective partnerships across teams, government agencies, community resources, and independent-sector resources are central to providing the proper support in the right place for everyone. Such strategic initiatives are likely to offer growth opportunities to the market players to attain a significant position and grow in the market. Also, several manufacturers are working on advanced cardiac rehabilitation products. For instance, in April 2019, Royal Philips launched an ultrasonic system EPIQ CVx to offer excellent image clarity and sharpness, upgraded exam efficiencies, as well as more robust and reproducible quantification enabled by anatomical intelligence along with extraordinary processing power. Therefore, the adoption of technologically advanced cardiac rehabilitation products is likely to be a prevalent trend during the forecast period.
Countries in Asia-Pacific are expecting to witness massive challenges due to the growing COVID-19. Considering the economic operations and geographic conditions, the pandemic has affected medical tourism, manufacturers of medical equipment, and other problems posed by the shortage of healthcare infrastructure in Asia Pacific low-income countries. Due to rapidly changing risk of COVID-19 affected countries and always controlling outbreak trends, any additional health measures are likely to interfere with international travel and trade significantly. This is likely to have negative impact on the Asia Pacific cardiac rehabilitation market.d
The growth of the market is attributed to some key driving factors such as rise in technologically advanced cardiac rehabilitation products and supportive government initiatives for cardiac rehabilitation. However, the high cost of the cardiac rehabilitation equipment is expected to obstruct the growth of the market to a certain extent during the forecast years.
Halma plc, OMRON Corporation, Koninklijke Philips N.V, General Electric Company, Core Health & Fitness, LLC, and Resideo Technologies, Inc., are among the leading companies operating in the Asia Pacific cardiac rehabilitation market.
The report segments in Asia Pacific Cardiac Rehabilitation Market as follows:
By Product
By Application
By End User
By Country
The Asia Pacific cardiac rehabilitation market, by type, is segmented into heart rate monitor, stabilization balls, treadmill, rower, elliptical trainer, blood pressure monitor, stationary bicycle, and others. The treadmill segment held the largest share of the market in 2020, whereas the blood pressure monitor segment is anticipated to register the highest CAGR in the market during the forecast period.
CR is an evidence-based, multidisciplinary intervention conferred to enhance health consequences and quality of life when used as secondary prevention. Several government initiatives are considered to have a high impact on the market. Increasing awareness regarding the CR, growing referral of eligible patients, and reducing system and limitations of the patient cooperation in promoting the enrolment, referral, and participation rates in CR programs. Several manufacturers are working on advanced cardiac rehabilitation products. Effective partnerships across teams, government agencies, community resources, and independent-sector resources are central to providing the proper support in the right place for everyone. Such strategic initiatives are likely to offer growth opportunities to the market players to attain a significant position and grow in the market. Also, several manufacturers are working on advanced cardiac rehabilitation products. For instance, in April 2019, Royal Philips launched an ultrasonic system EPIQ CVx to offer excellent image clarity and sharpness, upgraded exam efficiencies, as well as more robust and reproducible quantification enabled by anatomical intelligence along with extraordinary processing power. Therefore, the adoption of technologically advanced cardiac rehabilitation products is likely to be a prevalent trend during the forecast period.
Countries in Asia-Pacific are expecting to witness massive challenges due to the growing COVID-19. Considering the economic operations and geographic conditions, the pandemic has affected medical tourism, manufacturers of medical equipment, and other problems posed by the shortage of healthcare infrastructure in Asia Pacific low-income countries. Due to rapidly changing risk of COVID-19 affected countries and always controlling outbreak trends, any additional health measures are likely to interfere with international travel and trade significantly. This is likely to have negative impact on the Asia Pacific cardiac rehabilitation market.d
The growth of the market is attributed to some key driving factors such as rise in technologically advanced cardiac rehabilitation products and supportive government initiatives for cardiac rehabilitation. However, the high cost of the cardiac rehabilitation equipment is expected to obstruct the growth of the market to a certain extent during the forecast years.
Halma plc, OMRON Corporation, Koninklijke Philips N.V, General Electric Company, Core Health & Fitness, LLC, and Resideo Technologies, Inc., are among the leading companies operating in the Asia Pacific cardiac rehabilitation market.
The report segments in Asia Pacific Cardiac Rehabilitation Market as follows:
By Product
- Treadmill
- Elliptical Trainer
- Stationary Bicycle
- Blood Pressure Monitor
- Rower
- Heart Rate Monitor
- Stabilization Balls
- Others
By Application
- Angioplasty
- Coronary Artery Disease
- Cardiomyopathy
- Cholesterol Management
- Diabetes
- Lung Transplant
By End User
- Cardiac Rehabilitation Centers
- Home Healthcare
- Specialty Hospitals
- Hospitals & Clinics
- Others
By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Cardiac Rehabilitation Market - Market Landscape
5. Cardiac Rehabilitation Market - Key Market Dynamics
6. Cardiac Rehabilitation Market - Asia Pacific Analysis
7. Cardiac Rehabilitation Market Analysis - By Products
8. Cardiac Rehabilitation Market Analysis - By Application
9. Cardiac Rehabilitation Market- By End User
10. Cardiac Rehabilitation Market - Asia Pacific Analysis
11. Impact Of COVID-19 Pandemic on Asia Pacific Cardiac Rehabilitation Market
12. Cardiac Rehabilitation Market-Industry Landscape
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Halma plc
- OMRON Corporation
- Koninklijke Philips N.V
- General Electric Company
- Core Health & Fitness, LLC
- Resideo Technologies, Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 154 |
| Published | June 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 357.64 Million |
| Forecasted Market Value ( USD | $ 566.21 Million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Asia Pacific |
